1. The Human Genome Project
2. Massively parallel DNA sequencing
3. Personalizing therapeutics via companion diagnostic tests (Herceptin, Gleevec, OncoDX, …)
4. Advanced diagnostics by blood biomarker analysis (e.g. fetal DNA/cells in mother’s blood)
5. The launch of the field of systems biology
[Editor’s Note: This is part of a series of posts from Xconomists and other technology leaders from around the country who are weighing in with the top innovations they’ve seen in their respective fields the past 10 years, or the top disruptive technologies that will impact the next decade.]
Author: Clifford Reid
Clifford Reid is chairman, president and chief executive officer of Complete Genomics. He has 25 years of experience in startup and growth companies managing the commercialization of innovative, unstructured data management technologies. In 1995, he was the founding chairman and chief executive officer of Eloquent, Inc., a digital video communications company that he took public in 2000 (NASDAQ: ELOQ) and sold it in 2003. In 1988, he was the founding vice president of product development at Verity (NASDAQ: VRTY), an enterprise text search engine company that was recently sold to Autonomy for $500 million. Cliff earned a B.S. in physics from the Massachusetts Institute of Technology (MIT), an M.B.A. from the Harvard Business School and a Ph.D. in management science and engineering (MSE) from Stanford University.
View all posts by Clifford Reid
